Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot ...
Early return to protected weightbearing at an average 7.5 days; Clinically significant improvement relative to baseline in radiographic measures of both midfoot (metatarsus adductus) and 3D bunion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback